Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Development and Validation of a Robust Ferroptosis-Related Prognostic Signature in Lung Adenocarcinoma
Anran Zhang, Jinpo Yang, Chao Ma, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 84

Showing 1-25 of 84 citing articles:

Metabolism-regulated ferroptosis in cancer progression and therapy
Lvlan Ye, Xiangqiong Wen, Jiale Qin, et al.
Cell Death and Disease (2024) Vol. 15, Iss. 3
Open Access | Times Cited: 25
Ferroptosis in Non-Small Cell Lung Cancer: Progression and Therapeutic Potential on It
Jiayu Zou, Li Wang, Hailin Tang, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 24, pp. 13335-13335
Open Access | Times Cited: 80
The interplay of oncogenic signaling, oxidative stress and ferroptosis in cancer
Wentao Zeng, Xiaohang Long, Pu‐Ste Liu, et al.
International Journal of Cancer (2023) Vol. 153, Iss. 5, pp. 918-931
Closed Access | Times Cited: 37
Molecular subtypes of lung adenocarcinoma patients for prognosis and therapeutic response prediction with machine learning on 13 programmed cell death patterns
Qin Wei, Xiaoyu Jiang, Xinyi Miao, et al.
Journal of Cancer Research and Clinical Oncology (2023) Vol. 149, Iss. 13, pp. 11351-11368
Closed Access | Times Cited: 28
A Prognostic Risk Score Based on Hypoxia-, Immunity-, and Epithelialto-Mesenchymal Transition-Related Genes for the Prognosis and Immunotherapy Response of Lung Adenocarcinoma
Wenhao Ouyang, Yupeng Jiang, Shiyi Bu, et al.
Frontiers in Cell and Developmental Biology (2022) Vol. 9
Open Access | Times Cited: 32
Immune, metabolic landscapes of prognostic signatures for lung adenocarcinoma based on a novel deep learning framework
Shimei Qin, Shibin Sun, Yahui Wang, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 6
Ferroptosis in age-related vascular diseases: Molecular mechanisms and innovative therapeutic strategies
Yue Dai, Xiuxian Wei, Tao Jiang, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 173, pp. 116356-116356
Open Access | Times Cited: 6
Prognostic Ferroptosis-Related lncRNA Signatures Associated With Immunotherapy and Chemotherapy Responses in Patients With Stomach Cancer
Donglin Lai, Lin Tan, Xiaojia Zuo, et al.
Frontiers in Genetics (2022) Vol. 12
Open Access | Times Cited: 27
Machine Learning-Based Integration Develops a Macrophage-Related Index for Predicting Prognosis and Immunotherapy Response in Lung Adenocarcinoma
Zuwei Li, Minzhang Guo, Wanli Lin, et al.
Archives of Medical Research (2023) Vol. 54, Iss. 7, pp. 102897-102897
Closed Access | Times Cited: 13
Ferroptosis: Molecular perspective, cellular influence, cancer manifestation, and therapeutic potentials
Pawan Kumar Pandey, Saurabh Bhorkade, Shikha Jha, et al.
Journal of Drug Delivery Science and Technology (2024) Vol. 100, pp. 105998-105998
Closed Access | Times Cited: 5
Identification of Five Ferroptosis-Related LncRNAs as Novel Prognosis and Diagnosis Signatures for Renal Cancer
Xiangjun Shu, Zaiqi Zhang, Zhi-Yong Yao, et al.
Frontiers in Molecular Biosciences (2022) Vol. 8
Open Access | Times Cited: 22
Immunometabolism in the tumor microenvironment and its related research progress
Ziheng Zhang, Yajun Hu, Yuefeng Chen, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 21
Prognosis and personalized treatment prediction in lung adenocarcinoma: An in silico and in vitro strategy adopting cuproptosis related lncRNA towards precision oncology
Chao Ma, Feng Li, Zhanfeng He, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 12
Time-restricted feeding protects against septic liver injury by reshaping gut microbiota and metabolite 3-hydroxybutyrate
Jingjuan Hu, Fan Deng, Qi‐Shun Sun, et al.
Gut Microbes (2025) Vol. 17, Iss. 1
Open Access
Multi-omics integration reveals YWHAE as a key mediator of ferroptosis in ARDS
Heng Cui, Xia Huang
Functional & Integrative Genomics (2025) Vol. 25, Iss. 1
Closed Access
Ferroptosis in Lung Cancer: From Molecular Mechanisms to Prognostic and Therapeutic Opportunities
Peyman Tabnak, Zanyar HajiEsmailPoor, Soroush Soraneh
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 27
Construction and validation of a novel gene signature for predicting the prognosis of osteosarcoma
Jinpo Yang, Anran Zhang, Huan Luo, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 18
Identification of cuproptosis-related subtypes in lung adenocarcinoma and its potential significance
Shize Pan, Congkuan Song, Heng Meng, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 13
A novel DNA methylation signature to improve survival prediction of progression-free survival for testicular germ cell tumors
Feng Gao, Qiaoping Xu, Yingjun Jiang, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 7
Comprehensive Analysis of Programmed Cell Death Signature in the Prognosis, Tumor Microenvironment and Drug Sensitivity in Lung Adenocarcinoma
Shize Pan, Heng Meng, Tao Fan, et al.
Frontiers in Genetics (2022) Vol. 13
Open Access | Times Cited: 12
Prognosis and Immunotherapy Response With a Novel Golgi Apparatus Signature-Based Formula in Lung Adenocarcinoma
Yupeng Jiang, Wenhao Ouyang, Chenzi Zhang, et al.
Frontiers in Cell and Developmental Biology (2022) Vol. 9
Open Access | Times Cited: 11
The novel miR-873-5p-YWHAE-PI3K/AKT axis is involved in non-small cell lung cancer progression and chemoresistance by mediating autophagy
Li Z, Jinglei Liu, Ping Wang, et al.
Functional & Integrative Genomics (2024) Vol. 24, Iss. 2
Closed Access | Times Cited: 2
Transcription factor NFYA inhibits ferroptosis in lung adenocarcinoma cells by regulating PEBP1
Feng Chen, Tingting Xu, Ni Jin, et al.
Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis (2024) Vol. 829, pp. 111873-111873
Closed Access | Times Cited: 2
COPZ1 regulates ferroptosis through NCOA4-mediated ferritinophagy in lung adenocarcinoma
A. M. Wu, Hongmin Yang, Tengfei Xiao, et al.
Biochimica et Biophysica Acta (BBA) - General Subjects (2024) Vol. 1868, Iss. 11, pp. 130706-130706
Open Access | Times Cited: 2
Transmembrane p24 trafficking protein 2 regulates inflammation through the TLR4/NF-κB signaling pathway in lung adenocarcinoma
Longhua Feng, Pengjiang Cheng, Zheng-yun Feng, et al.
World Journal of Surgical Oncology (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 10
Page 1 - Next Page

Scroll to top